Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. In the last 30 years several neuroprotective agents, attenuating the downstream molecular and cellular damaging events triggered by TBI, have been extensively studied. Even though many drugs have shown promising resul...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Front Neurol
Main Authors: Carbonara, Marco, Fossi, Francesca, Zoerle, Tommaso, Ortolano, Fabrizio, Moro, Federico, Pischiutta, Francesca, Zanier, Elisa R., Stocchetti, Nino
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2018
נושאים:
Neurology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6208094/
https://ncbi.nlm.nih.gov/pubmed/30405517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00885
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים